share_log

Raymond James Initiates Coverage On Pacira BioSciences With Outperform Rating, Announces Price Target of $42

Benzinga ·  Dec 20, 2023 06:31

Raymond James analyst Gary Nachman initiates coverage on Pacira BioSciences (NASDAQ:PCRX) with a Outperform rating and announces Price Target of $42.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment